1. A Combination of Deworming and Prime-Boost Vaccination Regimen Restores Efficacy of Vaccination Against Influenza in Helminth-Infected Mice.
- Author
-
Stetter N, Hartmann W, Brunn ML, Stanelle-Bertram S, Gabriel G, and Breloer M
- Subjects
- Animals, Coinfection immunology, Coinfection parasitology, Coinfection virology, Disease Models, Animal, Female, Filariasis immunology, Filariasis parasitology, Filariasis virology, Filarioidea immunology, Humans, Immunization, Secondary, Immunomodulation, Influenza A Virus, H1N1 Subtype immunology, Influenza, Human immunology, Influenza, Human parasitology, Influenza, Human virology, Mebendazole administration & dosage, Mebendazole analogs & derivatives, Mice, Mites parasitology, Sigmodontinae parasitology, Vaccination methods, Antinematodal Agents administration & dosage, Coinfection therapy, Filariasis therapy, Influenza Vaccines administration & dosage, Influenza, Human therapy
- Abstract
Helminths still infect a quarter of the human population. They manage to establish chronic infections by downmodulating the immune system of their hosts. Consequently, the immune response of helminth-infected individuals to vaccinations may be impaired as well. Here we study the impact of helminth-induced immunomodulation on vaccination efficacy in the mouse system. We have previously shown that an underlying Litomosoides sigmodontis infection reduced the antibody (Ab) response to anti-influenza vaccination in the context of a systemic expansion of type 1 regulatory T cells (Tr1). Most important, vaccine-induced protection from a challenge infection with the 2009 pandemic H1N1 influenza A virus (2009 pH1N1) was impaired in vaccinated, L. sigmodontis- infected mice. Here, we aim at the restoration of vaccination efficacy by drug-induced deworming. Treatment of mice with Flubendazole (FBZ) resulted in elimination of viable L. sigmodontis parasites in the thoracic cavity after two weeks. Simultaneous FBZ-treatment and vaccination did not restore Ab responses or protection in L. sigmodontis- infected mice. Likewise, FBZ-treatment two weeks prior to vaccination did not significantly elevate the influenza-specific Ig response and did not protect mice from a challenge infection with 2009 pH1N1. Analysis of the regulatory T cell compartment revealed that L. sigmodontis- infected and FBZ-treated mice still displayed expanded Tr1 cell populations that may contribute to the sustained suppression of vaccination responses in successfully dewormed mice. To outcompete this sustained immunomodulation in formerly helminth-infected mice, we finally combined the drug-induced deworming with an improved vaccination regimen. Two injections with the non-adjuvanted anti-influenza vaccine Begripal conferred 60% protection while MF59-adjuvanted Fluad conferred 100% protection from a 2009 pH1N1 infection in FBZ-treated, formerly L. sigmodontis- infected mice. Of note, applying this improved prime-boost regimen did not restore protection in untreated L. sigmodontis- infected mice. In summary our findings highlight the risk of failed vaccinations due to helminth infection., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Stetter, Hartmann, Brunn, Stanelle-Bertram, Gabriel and Breloer.)
- Published
- 2021
- Full Text
- View/download PDF